
Quotient Sciences Recognized as a Winner of 2025 CDMO Leadership Awards
Read More36 - 40 of 154 results
In the rapidly evolving bio/pharmaceutical industry, integrating advanced technologies and patient-centric strategies is crucial for formulation success. This article by Pharma Tech explores how digitalization, artificial intelligence (AI),...
Learn moreIn this article by the Manufacturing Chemist, Dr Andy Lewis, Chief Scientific Officer at Quotient Sciences reviews the trends driving the adoption of oral peptide products and considers the strategies to overcome the development challenges ...
Learn moreIn this article by the Medicine Maker, Richard Castledine discusses how to identify a safe, cost-efficient, and sustainable route to scalable API synthesis.The article explores the complexities of developing Active Pharmaceutical Ingredient...
Learn moreThis article by Drug Development & Delivery highlights the importance of Contract Development and Manufacturing Organizations (CDMOs) for the pharma and biotech companies when it comes to advancing innovative therapies. In ...
Learn moreIn this article by the Medicine Maker, Asma Patel and John McDermott talk about the complexities of developing modified release formulations.These formulations allow more control over drug release in the gastrointestinal (GI) tract, providi...
Learn more